Pancreatic Disorders

Top Story

THC tablets fail to reduce chronic abdominal pain

July 18, 2017

Oral tablets containing purified tetrahydrocannabinol, or THC, failed to improve chronic abdominal pain better than placebo in a phase 2 randomized controlled trial.

Researchers noted that oral THC “showed acceptable safety and tolerability profiles” as an add-on treatment, and that “further research should evaluate the effects of THC on secondary and tertiary central pain processing.”

Trial designed to better understand link between pancreatic cancer, newly diagnosed diabetes

July 18, 2017
A new trial has been launched to help researchers better understand the link between new-onset diabetes and pancreatic cancer. Researchers also hope to identify…
In the Journals

New study further validates Cellvizio for diagnosing pancreatic cysts

July 17, 2017
Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy using the Cellvizio platform was effective for optical biopsy of pancreatic cysts, supporting its…

NYU Langone launches program to target pancreatic cancer

July 17, 2017
The Perlmutter Cancer Center at NYU Langone Medical Center has launched their new Pancreatic Cancer Center, a multidisciplinary center to improve the diagnosis…
More Headlines »
CME

The Transplant Patient with HCV Infection

No commercial support for this activity.

HCV-associated liver disease necessitates the need for liver transplantation more than any other condition. This…
More »
GI Bookshelf

Chapter 31: Rectal Bleeding Following Craniotomy

From Complicated Cases in GI
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Video
Meeting News Coverage

VIDEO: Cholangioscopy, pancreatoscopy advances improve management of biliary, pancreatic disorders

May 22, 2016
More »
Advertisement
Advertisement